BioAdvance announced investments of up to $500,000 in 7 (seven) life science companies in the Philadelphia-area. Press releases are here. These companies range from diagnostics to cancer therapeutics to drug delivery. This is yet another example of what other areas are doing to help their life science companies. Yet I firmly believe we can do this in New York as well. I (and others) will continue to work to make this happen in New York.
Comments